Mucolipidosis type IV: clinical manifestations and natural history. 1991

D Chitayat, and C M Meunier, and K A Hodgkinson, and K Silver, and M Flanders, and I J Anderson, and J M Little, and D A Whiteman, and S Carpenter
Department of Pediatrics, Montreal Childrens Hospital, Quebec, Canada.

The clinical manifestations and psychomotor development of five patients with mucolipidosis IV (MLIV) from three Ashkenazi-Jewish families are reported. The presenting symptoms were hypotonia, developmental delay, corneal clouding, and puffy eyelids. Four of the patients had convergent strabismus and none progressed beyond a developmental age of 15 months. One patient died of aspiration at 17 years while the oldest patient entered puberty at 20 years, developed a coarse face at 30 years, and is now 32 years old. Histopathological studies in four patients showed storage changes characteristic of MLIV.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007585 Jews An ethnic group with historical ties to the land of ISRAEL and the religion of JUDAISM. Jew
D008297 Male Males
D009081 Mucolipidoses A group of inherited metabolic diseases characterized by the accumulation of excessive amounts of acid mucopolysaccharides, sphingolipids, and/or glycolipids in visceral and mesenchymal cells. Abnormal amounts of sphingolipids or glycolipids are present in neural tissue. INTELLECTUAL DISABILITY and skeletal changes, most notably dysostosis multiplex, occur frequently. (From Joynt, Clinical Neurology, 1992, Ch56, pp36-7) Cherry Red Spot Myoclonus Syndrome,Ganglioside Sialidase Deficiency Disease,I-Cell Disease,Lipomucopolysaccharidosis,Mucolipidosis,Myoclonus Cherry Red Spot Syndrome,Pseudo-Hurler Polydystrophy,Sialidosis,Cherry Red Spot-Myoclonus Syndrome,Deficiency Disease, Ganglioside Sialidase,Glycoprotein Neuraminidase Deficiency,Inclusion Cell Disease,Mucolipidosis I,Mucolipidosis II,Mucolipidosis III,Mucolipidosis III Alpha Beta,Mucolipidosis IIIa,Mucolipidosis IV,Mucolipidosis Type 1,Mucolipidosis Type I,Mucolipidosis Type II,Mucolipidosis Type III,Mucolipidosis Type IV,Myoclonus-Cherry Red Spot Syndrome,Psuedo-Hurler Disease,Sialolipidosis,Type I Mucolipidosis,Type II Mucolipidosis,Type III Mucolipidosis,Type IV Mucolipidosis,Deficiencies, Glycoprotein Neuraminidase,Deficiency, Glycoprotein Neuraminidase,Glycoprotein Neuraminidase Deficiencies,I Cell Disease,I-Cell Diseases,Inclusion Cell Diseases,Lipomucopolysaccharidoses,Mucolipidoses, Type I,Mucolipidoses, Type II,Mucolipidoses, Type III,Mucolipidoses, Type IV,Mucolipidosis, Type I,Mucolipidosis, Type II,Mucolipidosis, Type III,Mucolipidosis, Type IV,Polydystrophy, Pseudo-Hurler,Pseudo Hurler Polydystrophy,Psuedo Hurler Disease,Psuedo-Hurler Diseases,Sialidoses,Sialolipidoses,Type I Mucolipidoses,Type II Mucolipidoses,Type III Mucolipidoses,Type IV Mucolipidoses
D011596 Psychomotor Disorders Abnormalities of motor function that are associated with organic and non-organic cognitive disorders. Psychomotor Impairment,Developmental Psychomotor Disorders,Psychomotor Disorders, Developmental,Developmental Psychomotor Disorder,Impairment, Psychomotor,Impairments, Psychomotor,Psychomotor Disorder, Developmental,Psychomotor Impairments
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003316 Corneal Diseases Diseases of the cornea. Corneal Disease,Disease, Corneal,Diseases, Corneal
D005260 Female Females
D005808 Genes, Recessive Genes that influence the PHENOTYPE only in the homozygous state. Conditions, Recessive Genetic,Genetic Conditions, Recessive,Recessive Genetic Conditions,Condition, Recessive Genetic,Gene, Recessive,Genetic Condition, Recessive,Recessive Gene,Recessive Genes,Recessive Genetic Condition

Related Publications

D Chitayat, and C M Meunier, and K A Hodgkinson, and K Silver, and M Flanders, and I J Anderson, and J M Little, and D A Whiteman, and S Carpenter
June 1987, Pediatrics,
D Chitayat, and C M Meunier, and K A Hodgkinson, and K Silver, and M Flanders, and I J Anderson, and J M Little, and D A Whiteman, and S Carpenter
April 2022, Neurology. Genetics,
D Chitayat, and C M Meunier, and K A Hodgkinson, and K Silver, and M Flanders, and I J Anderson, and J M Little, and D A Whiteman, and S Carpenter
April 1988, Pediatrics,
D Chitayat, and C M Meunier, and K A Hodgkinson, and K Silver, and M Flanders, and I J Anderson, and J M Little, and D A Whiteman, and S Carpenter
July 2001, Molecular genetics and metabolism,
D Chitayat, and C M Meunier, and K A Hodgkinson, and K Silver, and M Flanders, and I J Anderson, and J M Little, and D A Whiteman, and S Carpenter
January 2022, Journal of pediatric ophthalmology and strabismus,
D Chitayat, and C M Meunier, and K A Hodgkinson, and K Silver, and M Flanders, and I J Anderson, and J M Little, and D A Whiteman, and S Carpenter
November 2011, Molecular genetics and metabolism,
D Chitayat, and C M Meunier, and K A Hodgkinson, and K Silver, and M Flanders, and I J Anderson, and J M Little, and D A Whiteman, and S Carpenter
December 2010, Biochemical Society transactions,
D Chitayat, and C M Meunier, and K A Hodgkinson, and K Silver, and M Flanders, and I J Anderson, and J M Little, and D A Whiteman, and S Carpenter
February 1998, Proceedings of the National Academy of Sciences of the United States of America,
D Chitayat, and C M Meunier, and K A Hodgkinson, and K Silver, and M Flanders, and I J Anderson, and J M Little, and D A Whiteman, and S Carpenter
February 2014, Molecular genetics and metabolism,
D Chitayat, and C M Meunier, and K A Hodgkinson, and K Silver, and M Flanders, and I J Anderson, and J M Little, and D A Whiteman, and S Carpenter
October 1979, Biochemical and biophysical research communications,
Copied contents to your clipboard!